Clinical Trials Sponsored by Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Total 172 results

Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Suspended

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

Advanced or Metastatic CRC

China
Sichuan University
Chengdu Brilliant Pharmaceutical Co., Ltd.

Not yet recruiting

Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC

Small Cell Lung Cancer Extensive Stage
Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd

Unknown

A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis

Patient of Anemia in Chronic Renal Failure With Hemodialysis

China
Sichuan Honghe Biotechnology Co., Ltd.

Recruiting

Phase 1 Trial of KH617

Advanced Solid Tumors

China
Beijing Kanghong Biopharmaceutical Co., Ltd.

Not yet recruiting

Phase 1 Trial of KH801

Advanced Solid Tumors

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Not yet recruiting

A Study of FZ-AD005 in Patients With Advanced Solid Tumors

Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Not yet recruiting

Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）

Malignant Glioma of Brain | 5-aminolevulinic Acid

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19

COVID-19

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Withdrawn

Clinical Study of Meplazumab to Treat With Malaria

Malaria (Plasmodium Falciparum)
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

Study to Assess the Effect of Meplazumab on COVID-19

COVID-19

Brazil
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain

Port-wine Stain

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris

Acne Vulgaris

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)

Cervical Intraepithelial Neoplasia | Papillomavirus Infections | Low-Grade Squamous Intraepithelial Lesions

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia

Cervical Intraepithelial Neoplasia | Cervical Persistent High Risk HPV Infection

China
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Unknown

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Osteosarcoma

China
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Completed

Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Not yet recruiting

A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors

Advanced Solid Tumor

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Recruiting

Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed With Plasmodium Falciparum

Malaria

Kenya
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Recruiting

A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors

Advanced Solid Tumors

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection

Papillomavirus Infections | Cervical Intraepithelial Neoplasia Grade 2 | p16 Protein

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.

Refractory or Recurrent CD30+ Hematologic Malignancies

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Pharmacokinetics and Safety of ALA in Acne Vulgaris

Acne Vulgaris

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Terminated

Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma

Hilar Cholangiocarcinoma

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer

Ovarian Cancer

China
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Completed

Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

Small Cell Lung Cancer

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers

Healthy

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Recruiting

A Study of FZ-AD004 in Patients With Advanced Solid Tumors

Advanced and Metastatic Solid Tumor

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Recruiting

A Study of FDA018-ADC in Patients With Advanced Solid Tumors

Advanced/ Metastatic Solid Tumors

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Not yet recruiting

A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin + PDT

Port-Wine Stain | Nevus Flammeus | Port-wine Birthmark
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Recruiting

Phase 1 Study to Evaluate Safety and Pharmacokinetics of FZJ-003 in Healthy Volunteers

Healthy Volunteers

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19

Post-COVID-19

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain

Port-wine Stain

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain

Port-Wine Stain

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Withdrawn

Study on the Safety and Efficacy of Meplazumab for Injection Patients COVID-19

COVID-19

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

the Safety and Efficacy of Meplazumab in Patients With COVID-19

Covid19

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers

Rheumatic Diseases

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Terminated

Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)

Rheumatoid Arthritis

China
Shanghai Bao Pharmaceuticals Co., Ltd.

Active, not recruiting

A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults

Healthy

New Zealand
Chengdu Zenitar Biomedical Technology Co., Ltd

Not yet recruiting

Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors

Myeloproliferative Neoplasm (MPN) | Myelofibrosis，MF
Shanghai Yiteng Jingang Bio-pharmaceutical Technology...

Recruiting

A Study of EOC237 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

China
Azidus Brasil
Boya Bio Pharmaceutical Group Co Ltd

Not yet recruiting

Efficacy and Safety and Pharmacokinetics of Boya IVIG (Boya)

Primary Immunodeficiency Disease
Sichuan Baili Pharmaceutical Co., Ltd.
Peking University First Hospital; Beijing Hospital

Unknown

Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection

Ventricular Fibrillation | Ventricular Tachycardia

China
Peking Union Medical College Hospital
Chengdu Yunke Pharmaceutical Co., Ltd.

Completed

A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis

Arthritis, Psoriatic

China
Beijing Tongren Hospital
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Completed

Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis

Seasonal Allergic Rhinitis

China
Beijing Tongren Hospital
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua

Allergic Rhinitis

China
National Cheng-Kung University Hospital
Pro-bio Biotech Co. Ltd.

Unknown

Probiotics Use in the Chronic Peritoneal Dialysis Patients

Malnutrition | Peritonitis

Taiwan
Shanghai JMT-Bio Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

China
Shanghai JMT-Bio Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer | EGFR Exon20 Insertion Mutations
Shanghai JMT-Bio Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

China
Shanghai JMT-Bio Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM

Hypercalcemia of Malignancy

Clinical Trials Sponsored by Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations